Okyanos Heart Institute Inks Deal With International Med-X and Philips Healthcare For Cardiac Cath Lab Equipment To Treat Heart Disease Patients With Adult Stem Cell Therapy
Freeport, The Bahamas (PRWEB) August 26, 2013
Okyanos Heart Institute, whose mission is to bring a new standard of care and better quality of life to patients with coronary artery disease using cardiac stem cell therapy, announces that it has selected International Med-X and Philips Healthcare as its partner to establish the country’s first cath lab for stem cell therapy.
Philips is a global leader in cardiac imaging and has the largest share of the market of cardiac cath labs worldwide. International Med-X is the distributor for Philips Healthcare equipment in most of the English and Dutch-speaking Caribbean including The Bahamas offering sales and service for all Philips Healthcare products. Chief Medical Officer Howard T. Walpole, Jr., M.D., M.B.A., F.A.C.C., F.S.C.A.I. made the decision to go with Philips equipment specifically for the treatment of adult stem cell therapy.
“The most important functions of this equipment are to provide high quality images and to obtain the right projections of the image." said Walpole. “When you visualize a heart, you need to be able to get a complex angle to be able to see the back side of the heart. This enables the cardiologist to deliver the stem cells where they are most needed. The size of the image detector is smaller and the more flexible positioner makes it easier to pivot around the patient’s body to obtain those difficult views.”
The cath lab was shipped from Holland and is currently in Miami awaiting delivery to The Bahamas. Okyanos Heart Institute plans to begin treating patients in early 2014.